ESC Premium Access

The diagnosis of non-adherence in hypertension using a urine biochemical screen is unaffected by drug pharmacokinetics

Congress Presentation

About the speaker

Mr Dan Lane

University Hospital of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)
0 follower

9 more presentations in this session

Dose antihypertensive medication improve accelerated age-dependent decline of GFR in hypertension?

Speaker: Doctor H. Takase (Hamamatsu, JP)

Thumbnail

Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes

Speaker: Miss S. Jung (Erlangen, DE)

Thumbnail

Effect of sodium glucose cotransporter 2 inhibitor on sympathetic nerve activity in type 2 diabetes mellitus patients

Speaker: Doctor T. Hamaoka (Kanazawa, JP)

Thumbnail

Adverse effects of spironolactone in long-term treatment of resistant arterial hypertension

Speaker: Associate Professor J. Vaclavik (Ostrava, CZ)

Thumbnail

The administration of an aldosterone antagonist as the second step of treatment improves efficacy and adherence at all hypertensive levels

Speaker: Doctor V. Martire (La Plata, AR)

Thumbnail

Access the full session

Challenges in hypertension treatment

Speakers: Mr D. Lane, Doctor H. Takase, Miss S. Jung, Doctor T. Hamaoka, Associate Professor J. Vaclavik...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb